Search research articles
Contact Us
Filters
Showing results (861-870 of 911) with videos related to
Page
of 92
Sort By:
Arthritis and Rheumatism
|
March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial
P J Clements, W K Wong, E L Hurwitz, et al.
Human Gene Therapy
|
February 19, 2010
Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia
David A Weinstein, Catherine E Correia, Thomas Conlon, et al.
Plos One
|
July 18, 2025
Impact of SARS-CoV-2 on healthcare and essential workers: A longitudinal study of PROMIS-29 outcomes
Jocelyn Dorney, Imtiaz Ebna Mannan, Caitlin Malicki, et al.
Journal of Inherited Metabolic Disease
|
March 10, 2025
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)
David A Weinstein, Terry G Derks, David F Rodriguez-Buritica, et al.
Lancet (London, England)
|
March 10, 2019
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial
Susan S Huang, Edward Septimus, Ken Kleinman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)
John J Openshaw, Ji Chen, Robert Rodriguez, et al.
Open Forum Infectious Diseases
|
June 11, 2025
Association of SARS-CoV-2 With Health-related Quality of Life 1 Year After Illness Using Latent Transition Analysis
Lauren E Wisk, Michael Gottlieb, Peizheng Chen, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study
D Khanna, D E Furst, R D Hays, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 5, 2014
The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative
Michael Klompas, Deverick Anderson, William Trick, et al.
Arthritis and Rheumatism
|
April 29, 1998
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study
F M Wigley, J H Korn, M E Csuka, et al.
Page
of 92
Search research articles
Search
Showing results (861-870 of 911) with videos related to
Sort By:
Page
of 92
Arthritis and Rheumatism
|
March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial
P J Clements, W K Wong, E L Hurwitz, et al.
Human Gene Therapy
|
February 19, 2010
Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia
David A Weinstein, Catherine E Correia, Thomas Conlon, et al.
Plos One
|
July 18, 2025
Impact of SARS-CoV-2 on healthcare and essential workers: A longitudinal study of PROMIS-29 outcomes
Jocelyn Dorney, Imtiaz Ebna Mannan, Caitlin Malicki, et al.
Journal of Inherited Metabolic Disease
|
March 10, 2025
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)
David A Weinstein, Terry G Derks, David F Rodriguez-Buritica, et al.
Lancet (London, England)
|
March 10, 2019
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial
Susan S Huang, Edward Septimus, Ken Kleinman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)
John J Openshaw, Ji Chen, Robert Rodriguez, et al.
Open Forum Infectious Diseases
|
June 11, 2025
Association of SARS-CoV-2 With Health-related Quality of Life 1 Year After Illness Using Latent Transition Analysis
Lauren E Wisk, Michael Gottlieb, Peizheng Chen, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study
D Khanna, D E Furst, R D Hays, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 5, 2014
The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative
Michael Klompas, Deverick Anderson, William Trick, et al.
Arthritis and Rheumatism
|
April 29, 1998
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study
F M Wigley, J H Korn, M E Csuka, et al.
Page
of 92